Roles and indications for use of implantable defibrillator and resynchronization therapy in the prevention of sudden cardiac death in heart failure.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Works matching IS 13824147 AND DT 2016 AND VI 21 AND IP 4
Results: 10
1
2
Cardioprotection and thyroid hormones.
- Published in:
- 2016
- By:
- Publication type:
- journal article
3
The role of pharmacotherapy in the prevention of sudden cardiac death in patients with heart failure.
- Published in:
- 2016
- By:
- Publication type:
- journal article
4
Long-term efficacy of implantable cardiac resynchronization therapy plus defibrillator for primary prevention of sudden cardiac death in patients with mild heart failure: an updated meta-analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
5
Tissue thyroid hormones and thyronamines.
- Published in:
- 2016
- By:
- Publication type:
- journal article
6
Thyroid hormones and cardiac remodeling.
- Published in:
- 2016
- By:
- Publication type:
- journal article
7
Thyroid hormones and the heart.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
8
Thyroid hormones and heart failure.
- Published in:
- 2016
- By:
- Publication type:
- journal article
9
Genetic variations involved in sudden cardiac death and their associations and interactions.
- Published in:
- 2016
- By:
- Publication type:
- journal article
10
Sudden cardiac death in heart failure with preserved ejection fraction: a target for therapy?
- Published in:
- 2016
- By:
- Publication type:
- journal article